The murine monoclonal antibody (Mab) MBr1, raised against the breast c
ancer cell line MCF7, recognizes a saccharidic epitope overexpressed o
n a high percentage of human breast, ovary, and lung carcinomas, This
antigen was originally identified on the immunogen as a globe-series g
lycosphingolipid with an II-like determinant at its terminus (globe-II
), We report here the biological characterization of the entire globe-
II hexasaccharide and five synthetic oligosaccharides representing fra
gments of the entire structure and/or different anomeric configuration
s, Using competitive binding assays on live cells, we identified the r
esidues and the linkages essential for mimicry of the cellular antigen
s recognized by Mab MBr1 on the breast carcinoma cell line MCF7 and sm
all cell lung cancer cell line POVD, The terminal tetrasaccharidic fra
gment of globe-a is the oligosaccharide that most resembles the MBr1-d
efined epitope both on glycolipids and on glycoproteins, This informat
ion will help in the rational design of a highly specific reagent for
active specific immunotherapy of carcinomas overexpressing the MBr1-de
fined antigen.